Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Month: March 2024

A combination of approved drugs enhances the delivery of anti-bacterial medications to treat tuberculosis

Researchers have found that approved drugs that were originally shown to normalize blood vessels surrounding tumors (to improve […]

March 28, 2024 Uncategorized

New enzymatic cocktail can kill tuberculosis-causing mycobacteria

An enzymatic cocktail can kill a variety of mycobacterial species of bacteria, including those that cause tuberculosis.

March 28, 2024 Uncategorized

Safer, more efficient drug discovery

Researchers have discovered a safer and more efficient technique for testing new drugs while they are in development.

March 28, 2024 Uncategorized

Researchers create biocompatible nanoparticles to enhance systemic delivery of cancer immunotherapy

Researchers are enhancing immunotherapy effects against malignant tumors by developing and validating patent-ending poly (lactic-co-glycolic acid), or PLGA, […]

March 28, 2024 Uncategorized

Researchers discover a mechanism that could improve platinum-based cancer therapy

Researchers say they have discovered that the protein puromycin-sensitive aminopeptidase (NPEPPS) plays a role in regulating response to […]

March 28, 2024 Uncategorized

Physician associates: GMC calls for views on regulation

The General Medical Council has launched a consultation on how it will regulate physician associates (PAs) and anaesthesia […]

March 27, 2024 Uncategorized

US Supreme Court questions legitimacy of case seeking to ban mifepristone

US Supreme Court justices appeared sceptical when hearing oral arguments in a case seeking to ban mifepristone, questioning […]

March 27, 2024 Uncategorized

LifeArc provides £750,000 fund for clinical trial to treat neuroferritinopathy

The progressive and incurable brain disorder currently affects approximately 100 patients worldwide

March 27, 2024 DefINe, Ferriprox, LifeArc, Lipomed, neuroferritinopathy, News, ultra-rare genetic diseases, University of Cambridge

PhaSER Biomedical and the Sanders TDI partner for clinical drug discovery research

PhaSER will provide 8HUM mouse models for the TDI to accelerate a pipeline of novel therapeutic targets

March 27, 2024 8HUM, drug discovery, Memorial Sloan Ketterine Cancer Center, News, PhaSER Biomedical, Rockefeller University, Sanders Tri-Institutional Therapeutic Discovery Institute, Weill Cornell Medicine

Consultant erased in 2011 is allowed back on the medical register at his third attempt

A consultant obstetrician and gynaecologist has been allowed back on the medical register on his third attempt, 13 […]

March 27, 2024 Uncategorized

Posts navigation

Posts pagination

« Previous 1 2 3 … 16 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy